封面
市場調查報告書
商品編碼
1284285

到 2028 年蛋白質純化和分離市場預測 - 按產品、技術、應用、最終用戶和地區分列的全球分析

Protein Purification and Isolation Market Forecasts to 2028 - Global Analysis By Product, Technology, Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC,2022年全球蛋白質純化分離市場規模將達到82.4億美元,預計2028年將達到174億美元,預計複合年增長率為13.26% 2020年。

蛋白質純化是利用物理差異從細胞、組織和生物體的複雜混合物中去除蛋白質的過程。 蛋白質純化需要獲得大量純淨的功能性蛋白質。 為了獲得所需的蛋白質,該過程將蛋白質與混合物中的非蛋白質成分分離。 它們主要用於對蛋白質結構、功能和相互作用進行分類。 親和層析、免疫沉澱、蛋白質組學、□分析等是一些常用的蛋白質純化和分離技術。

根據Research America 2022年1月發布的一份報告,2020年生物製藥企業將投入約1222.04億美元,而2019年將投入約1109.32億美元用於研發。 因此,這些事實有望推動該國的市場增長。

市場動態:

驅動程序

對快速純化試劑盒的需求不斷增長

市場擴張的主要驅動力之一是發現新型配體(例如基於蛋白質的治療化合物)的重要性與日俱增。 全球蛋白質純化和分離市場受到對用於快速篩選、製備、純化和富集蛋白質樣品的快速純化試劑盒不斷增長的需求的推動。 此外,由於各種因素,例如公共和私人研究機構增加研發資金以及擴大對基於結構的藥物設計的研究,市場有望擴大。

約束

昂貴且耗時的過程

蛋白質純化和分離技術通常需要特殊的工具、試劑和人力資源,導致總體成本高昂。 對於資源有限的研究人員和機構來說,獲得此類技術的機會可能會受到限制。 此外,蛋白質純化和分離非常耗時,需要許多步驟,例如細胞裂解、層析和過濾。 蛋白質純化可能耗時、低效且不可擴展。

機會

政府投資增加

政府增加研發投資以及鼓勵研發增長和擴張的計劃將使製藥和生物技術行業受益。 額外的好處包括補貼、法規和稅收優惠。 對生物標誌物特異性分子研發的大量投資使製藥行業成為蛋白質純化和分離產品的高利潤市場。

威脅

缺乏通用的純化技術或法規要求

蛋白質純化和分離過程可能需要遵守監管要求和質量標準,尤其是在生物技術和製藥應用中。 為滿足這些要求,整個過程可能會變得更加複雜和昂貴。 此外,還沒有能夠成功分離和純化所有類型蛋白質的純化技術。 不同的蛋白質可能需要以特定的方式進行純化以適應它們的特性,從而使過程更加複雜和多變。

COVID-19 的影響:

蛋白質純化和分離市場受到 COVID-19 供應鏈中斷和交付製造用於蛋白質純化和分離的試劑盒、試劑和消耗品所需的關鍵材料的延遲的負面影響。 由於卡車運輸瓶頸和港口檢查、許多國家的出口禁令、運營中的製造設施減少以及運輸和製造貨物的醫療保健,大流行導致關鍵貨物的交付延誤。這給市場帶來了重大挑戰,例如工人短缺。 結果,這種情況最初阻礙了市場的增長。 然而,近年來隨著蛋白質純化和分離技術被用於分析和研究新出現的急性呼吸系統綜合症冠狀病毒 (SARS-CoV-2),需求有所增加。

在預測期內,消耗品部分預計將是最大的

在預測期內,耗材部分預計將在蛋白質純化和分離領域佔據最大的市場份額。 該細分市場的巨大市場份額主要是由於耗材在蛋白質純化中的頻繁使用以及學術和醫學研究機構以及製藥公司等各種最終用戶對生物製藥開發的興趣日益濃厚。。

超濾部分預計在預測期內表現出最高的複合年增長率

預計超濾部分在預測期內將呈現最高增長率。 超濾是一種用於去除液體中溶解的分子和非常小的顆粒的技術。 分子大小是分離的主要依據,但樣品的化學、分子和靜電特性也會影響過濾器的滲透性。 蛋白質和緩衝液組分通常使用超濾分離,用於緩衝液交換、濃縮和脫鹽。 超濾的優勢及其在蛋白質純化和分離中的廣泛應用是預測期內推動該細分市場增長的主要因素。

市場份額最高的地區:

由於蛋白質純化市場的眾多參與者、研發基礎設施的發展以及蛋白質組學技術的發展,在預測期內,北美將繼續主導全球蛋白質純化市場。 北美市場對技術先進的蛋白質分離技術的需求也受到蛋白質-蛋白質相互作用研究、目標識別、藥物篩選、蛋白質治療、生物標誌物發現、疾病監測和診斷測試等應用領域改進的推動。

複合年增長率最高的地區:

在預測期內,亞太地區預計增長良好。 該地區對蛋白質純化和分離解決方案的需求預計將受到政府在中國和印度等發展中國家建設醫療保健基礎設施的努力的推動。 此外,這些政府正在資助尖端純化和分離技術的開發。 此外,促進國內藥品生產和生物仿製藥大規模生產的努力也有助於擴大市場。

主要發展:

2022 年 6 月,默克和馬利肯理論化學中心合作開展了一個機器學習項目。 這項為期三年的合作將側重於開髮用於計算化學建模的新工具和新分子表示。

2022 年 4 月,Thermo Fisher Scientific 與 Matrix Clinical Trials 合作加強了其臨床研究解決方案。 服務科學的全球領導者 Thermo Fisher Scientific 旗下的 PPD 臨床研究業務與 Matrix Medical Network 提供的 Matrix Clinical Trials 將合作開展臨床試驗,以創新的分散式臨床試驗(DCT)解決方案提供給患者。

本報告內容

  • 區域和國家/地區細分市場份額評估
  • 向新進入者提出戰略建議
  • 2020、2021、2022、2025 和 2028 年的綜合市場數據
  • 市場趨勢(驅動因素、制約因素、機會、威脅、挑戰、投資機會、建議)
  • 根據市場預測在關鍵業務領域提出戰略建議
  • 競爭格局映射關鍵共同趨勢。
  • 公司簡介,包括詳細的戰略、財務狀況和近期發展
  • 映射最新技術進步的供應鏈趨勢

免費定制優惠:

購買此報告的客戶將獲得以下免費定制選項之一:

  • 公司簡介
    • 其他市場參與者的綜合概況(最多 3 家公司)
    • 主要參與者的 SWOT 分析(最多 3 家公司)
  • 區域細分
    • 根據客戶的要求對主要國家/地區的市場估計/預測/複合年增長率(注意:基於可行性檢查)。
  • 競爭基準
    • 根據產品組合、區域影響力和戰略聯盟對主要參與者進行基準測試

內容

第 1 章執行摘要

第二章前言

  • 概覽
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 數據挖掘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 調查來源
    • 主要研究來源
    • 二級研究來源
    • 假設

第三章市場趨勢分析

  • 司機
  • 約束因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第 4 章波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第 5 章全球蛋白質純化和分離市場:按產品分類

  • 儀器
  • 消耗品
    • 預裝柱
    • 蛋白質純化試劑盒
    • 蛋白質純化樹脂
    • 試劑
    • 磁珠
      • 標記磁珠
      • 未標記的磁珠
    • 其他消耗品

第 6 章全球蛋白質純化和分離市場:按技術分類

  • 超濾
  • 降水
  • 製備色譜
    • 親和層析
    • 固定化金屬離子親和層析 (IMAC)
    • 免疫親和層析 (IAC)
    • 基於珠子的層析
    • 離子交換層析
    • 反相色譜
    • 疏水電荷誘導層析
    • 體積排阻色譜
  • 電泳
    • 凝膠電泳
    • 等電聚焦
    • 毛細管電泳
  • 蛋白質印跡
  • 透析和滲濾
  • 離心

第 7 章全球蛋白質純化和分離市場:按應用

  • 發現生物標誌物
  • 疾病診斷和監測
  • 藥物篩選
  • 蛋白質療法
  • 蛋白質-蛋白質相互作用研究
  • 目標識別

第 8 章。全球蛋白質純化和分離市場:最終用戶

  • 學術醫療機構
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 委託研究組織 (CRO)

第 9 章。全球蛋白質純化和分離市場:區域

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東和非洲地區

第10章主要發展

  • 合同、夥伴關係、協作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Abcam plc
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • G.E. Healthcare Life Sciences
  • Kamada Ltd.
  • Lanleys International Inc.
  • Leaf Expression Systems
  • Major Science
  • Merck KGaA
  • MNPHARM
  • Mtibio
  • Noble Life Sciences, Inc.
  • Norgen Biotek Corporation
  • Promega Corporation
  • Qiagen N.V.
  • Sigma-Aldrich Corporation
  • Takara Bio Inc
  • Thermo Fischer Scientific, Inc.
Product Code: SMRC23117

According to Stratistics MRC, the Global Protein Purification and Isolation Market is accounted for $8.24 billion in 2022 and is expected to reach $17.40 billion by 2028 growing at a CAGR of 13.26% during the forecast period. Protein purification is the process of removing proteins using physical differences from complex mixtures of cells, tissues, or organisms. Large amounts of functional protein with few impurities are sought after by the protein purification procedure. In order to obtain the desired protein, the process separates proteins from non-protein components in a mixture. They are primarily used to categorize the protein's structure, function, and interactions. Affinity chromatography, immunoprecipitation, proteomics, or enzyme assays are a few of the frequently employed techniques for protein purification and isolation.

According to the report published by the Research America in January 2022, the biopharmaceutical companies invested around USD 122,204 million in 2020, wheras in 2019 the investment was around USD 110,932 million in R&D. Therefore, such fact is anticipated to drive the growth of the market in the country.

Market Dynamics:

Driver:

Increasing demand for rapid purification kits

One of the main factors fueling market expansion is the growing importance of discovering novel ligands, such as protein-based therapeutic compounds. The global protein purification and isolation market is being driven by the increasing demand for rapid purification kits to quickly screen, prepare, purify, and concentrate protein samples. The market is also expected to grow as a result of a number of factors, including increased funding from both public and private research organizations for R&D and expanding research in structure-based drug design.

Restraint:

High costs and time consuming process

Techniques for protein purification and isolation frequently require specialized tools, reagents, and personnel, which raises the overall cost. For researchers and institutions with limited resources, this may limit their access to these techniques. Additionally, the process of purifying and isolating proteins can be time-consuming and involve numerous steps, including cell lysis, chromatography, and filtration. Protein purification may be less effective and less scalable as a result of the drawn-out processes.

Opportunity:

Rising investments by governments

Increased government investments in R&D and programs fostering their growth and expansion benefit the pharmaceutical and biotechnology industries. Additionally, they offer benefits in the form of grants, regulations, and tax breaks. Due to the significant investments made in studying and creating molecules specific to biomarkers, the pharmaceutical industry is a very lucrative market for goods involving protein purification and isolation.

Threat:

Lack of universal purification techniques and regulatory requirements

Regulatory requirements and quality standards may apply to the protein purification and isolation process, particularly when it is used in biotechnology or pharmaceutical applications. The process as a whole may become more complicated and expensive due to compliance with these requirements. Additionally, there isn't a purification technique that can successfully isolate and purify every kind of protein. The process becomes more complex and variable as a result of the potential need for different proteins to be purified using specific methods tailored to their individual characteristics.

COVID-19 Impact:

The protein purification and isolation market was negatively impacted by the supply chain disruption caused by COVID-19 and the delay in the delivery of crucial goods needed for the production of the kits, reagents, and consumables used in protein purification and isolation. A pandemic presents the market with a number of significant challenges, such as trucking bottlenecks and port checkpoints that slow down deliveries of essential supplies, export bans imposed in many nations, a dearth of operational manufacturing facilities, and a shortage of healthcare workers to transport and produce goods. As a result, this situation initially prevented market growth. The use of protein purification and isolation techniques for analysis and research involving the ever-emerging acute respiratory syndrome coronavirus (SARS-CoV-2) has, however, led to an increase in demand in recent years.

The consumables segment is expected to be the largest during the forecast period

During the forecast period, the consumables segment is anticipated to hold the largest market share for protein purification and isolation. The significant market share of this sector is primarily attributable to the frequent use of consumables for protein purification and the attention paid to the development of biopharmaceuticals by a variety of end users, including academic and medical research institutions and pharmaceutical firms.

The ultrafiltration segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ultrafiltration segment is anticipated to grow at the highest rate. Ultrafiltration is a technique used to remove dissolved molecules and incredibly small particles from liquids. The size of the molecules serves as the main basis for separation, though the sample's chemical, molecular, or electrostatic properties may also have an impact on the filter's permeability. Proteins and buffer components are typically separated using ultrafiltration for buffer exchange, concentration, or desalination. Ultrafiltration's benefits and widespread use in protein purification and isolation are the primary factors driving the segment's growth over the forecast period.

Region with largest share:

The presence of numerous protein purification market players, a developed research and development infrastructure, and technological developments in the proteomics sector all contribute to North America's continued dominance of the global protein purification market over the forecast period. The demand for technologically advanced protein isolation technologies in the North American market is also being driven by improved application fields like protein-protein interaction studies, target identification, drug screening, protein therapeutics, biomarker discovery, disease monitoring, and diagnostic tests.

Region with highest CAGR:

Over the forecast period, Asia-Pacific is anticipated to experience lucrative growth. The demand for protein purification and isolation solutions in this region is expected to be driven by government initiatives for the development of healthcare infrastructure in developing nations like China and India. Moreover, these governments are funding the creation of cutting-edge purification and isolation techniques. Additionally, initiatives promoting domestic pharmaceutical production and the high volume of biosimilar production contribute to the market's expansion.

Key players in the market:

Some of the key players profiled in the Protein Purification and Isolation Market include Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher, G.E. Healthcare Life Sciences, Kamada Ltd., Lanleys International Inc., Leaf Expression Systems, Major Science, Merck KGaA, MNPHARM, Mtibio, Noble Life Sciences, Inc., Norgen Biotek Corporation, Promega Corporation, Qiagen N.V., Sigma-Aldrich Corporation, Takara Bio Inc and Thermo Fischer Scientific, Inc.

Key Developments:

In June 2022, Merck and Mulliken Center for Theoretical Chemistry Collaborated in Machine Learning Project. The three-year collaboration will focus on developing new tools for computational chemistry modeling and new molecular representations.

In April 2022, Thermo Fisher Scientific Enhanced Clinical Research Solutions in Collaboration with Matrix Clinical Trials. The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, and Matrix Clinical Trials, a Matrix Medical Network offering, collaborated to bring clinical trials to patients with an innovative decentralized clinical trial (DCT) solution.

Products Covered:

  • Instruments
  • Consumables

Technologies Covered:

  • Ultrafiltration
  • Precipitation
  • Preparative Chromatography
  • Electrophoresis
  • Western Blotting
  • Dialysis & Diafiltration
  • Centrifugation

Applications Covered:

  • Biomarker Discovery
  • Disease Diagnostics & Monitoring
  • Drug Screening
  • Protein Therapeutics
  • Protein-Protein Interaction Studies
  • Target Identification

End Users Covered:

  • Academic Medical Institutes
  • Hospitals & Diagnostics Centers
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Protein Purification and Isolation Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Consumables
    • 5.3.1 Prepacked Columns
    • 5.3.2 Protein Purification Kits
    • 5.3.3 Protein Purification Resins
    • 5.3.4 Reagents
    • 5.3.5 Magnetic Beads
      • 5.3.5.1 Tagged Magnetic Beads
      • 5.3.5.2 Non-tagged Magnetic Beads
    • 5.3.6 Other Consumables

6 Global Protein Purification and Isolation Market, By Technology

  • 6.1 Introduction
  • 6.2 Ultrafiltration
  • 6.3 Precipitation
  • 6.4 Preparative Chromatography
    • 6.4.1 Affinity Chromatography
    • 6.4.2 Immobilized Metal Ion Affinity Chromatography (IMAC)
    • 6.4.3 Immunoaffinity Chromatography (IAC)
    • 6.4.4 Bead-Based Chromatography
    • 6.4.5 Ion Exchange Chromatography
    • 6.4.6 Reverse-Phase Chromatography
    • 6.4.7 Hydrophobic Charge Induction Chromatography
    • 6.4.8 Size Exclusion Chromatography
  • 6.5 Electrophoresis
    • 6.5.1 Gel Electrophoresis
    • 6.5.2 Isoelectric Focusing Electrophoresis
    • 6.5.3 Capillary Electrophoresis
  • 6.6 Western Blotting
  • 6.7 Dialysis & Diafiltration
  • 6.8 Centrifugation

7 Global Protein Purification and Isolation Market, By Application

  • 7.1 Introduction
  • 7.2 Biomarker Discovery
  • 7.3 Disease Diagnostics & Monitoring
  • 7.4 Drug Screening
  • 7.5 Protein Therapeutics
  • 7.6 Protein-Protein Interaction Studies
  • 7.7 Target Identification

8 Global Protein Purification and Isolation Market, By End User

  • 8.1 Introduction
  • 8.2 Academic Medical Institutes
  • 8.3 Hospitals & Diagnostics Centers
  • 8.4 Pharmaceutical & Biotechnology Companies
  • 8.5 Contract Research Organizations (CROs)

9 Global Protein Purification and Isolation Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abcam plc
  • 11.2 Agilent Technologies, Inc.
  • 11.3 Bio-Rad Laboratories, Inc.
  • 11.4 Danaher
  • 11.5 G.E. Healthcare Life Sciences
  • 11.6 Kamada Ltd.
  • 11.7 Lanleys International Inc.
  • 11.8 Leaf Expression Systems
  • 11.9 Major Science
  • 11.10 Merck KGaA
  • 11.11 MNPHARM
  • 11.12 Mtibio
  • 11.13 Noble Life Sciences, Inc.
  • 11.14 Norgen Biotek Corporation
  • 11.15 Promega Corporation
  • 11.16 Qiagen N.V.
  • 11.17 Sigma-Aldrich Corporation
  • 11.18 Takara Bio Inc
  • 11.19 Thermo Fischer Scientific, Inc.

List of Tables

  • Table 1 Global Protein Purification and Isolation Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Protein Purification and Isolation Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Protein Purification and Isolation Market Outlook, By Instruments (2020-2028) ($MN)
  • Table 4 Global Protein Purification and Isolation Market Outlook, By Consumables (2020-2028) ($MN)
  • Table 5 Global Protein Purification and Isolation Market Outlook, By Prepacked Columns (2020-2028) ($MN)
  • Table 6 Global Protein Purification and Isolation Market Outlook, By Protein Purification Kits (2020-2028) ($MN)
  • Table 7 Global Protein Purification and Isolation Market Outlook, By Protein Purification Resins (2020-2028) ($MN)
  • Table 8 Global Protein Purification and Isolation Market Outlook, By Reagents (2020-2028) ($MN)
  • Table 9 Global Protein Purification and Isolation Market Outlook, By Magnetic Beads (2020-2028) ($MN)
  • Table 10 Global Protein Purification and Isolation Market Outlook, By Other Consumables (2020-2028) ($MN)
  • Table 11 Global Protein Purification and Isolation Market Outlook, By Technology (2020-2028) ($MN)
  • Table 12 Global Protein Purification and Isolation Market Outlook, By Ultrafiltration (2020-2028) ($MN)
  • Table 13 Global Protein Purification and Isolation Market Outlook, By Precipitation (2020-2028) ($MN)
  • Table 14 Global Protein Purification and Isolation Market Outlook, By Preparative Chromatography (2020-2028) ($MN)
  • Table 15 Global Protein Purification and Isolation Market Outlook, By Affinity Chromatography (2020-2028) ($MN)
  • Table 16 Global Protein Purification and Isolation Market Outlook, By Immobilized Metal Ion Affinity Chromatography (IMAC) (2020-2028) ($MN)
  • Table 17 Global Protein Purification and Isolation Market Outlook, By Immunoaffinity Chromatography (IAC) (2020-2028) ($MN)
  • Table 18 Global Protein Purification and Isolation Market Outlook, By Bead-Based Chromatography (2020-2028) ($MN)
  • Table 19 Global Protein Purification and Isolation Market Outlook, By Ion Exchange Chromatography (2020-2028) ($MN)
  • Table 20 Global Protein Purification and Isolation Market Outlook, By Reverse-Phase Chromatography (2020-2028) ($MN)
  • Table 21 Global Protein Purification and Isolation Market Outlook, By Hydrophobic Charge Induction Chromatography (2020-2028) ($MN)
  • Table 22 Global Protein Purification and Isolation Market Outlook, By Size Exclusion Chromatography (2020-2028) ($MN)
  • Table 23 Global Protein Purification and Isolation Market Outlook, By Electrophoresis (2020-2028) ($MN)
  • Table 24 Global Protein Purification and Isolation Market Outlook, By Gel Electrophoresis (2020-2028) ($MN)
  • Table 25 Global Protein Purification and Isolation Market Outlook, By Isoelectric Focusing Electrophoresis (2020-2028) ($MN)
  • Table 26 Global Protein Purification and Isolation Market Outlook, By Capillary Electrophoresis (2020-2028) ($MN)
  • Table 27 Global Protein Purification and Isolation Market Outlook, By Western Blotting (2020-2028) ($MN)
  • Table 28 Global Protein Purification and Isolation Market Outlook, By Dialysis & Diafiltration (2020-2028) ($MN)
  • Table 29 Global Protein Purification and Isolation Market Outlook, By Centrifugation (2020-2028) ($MN)
  • Table 30 Global Protein Purification and Isolation Market Outlook, By Application (2020-2028) ($MN)
  • Table 31 Global Protein Purification and Isolation Market Outlook, By Biomarker Discovery (2020-2028) ($MN)
  • Table 32 Global Protein Purification and Isolation Market Outlook, By Disease Diagnostics & Monitoring (2020-2028) ($MN)
  • Table 33 Global Protein Purification and Isolation Market Outlook, By Drug Screening (2020-2028) ($MN)
  • Table 34 Global Protein Purification and Isolation Market Outlook, By Protein Therapeutics (2020-2028) ($MN)
  • Table 35 Global Protein Purification and Isolation Market Outlook, By Protein-Protein Interaction Studies (2020-2028) ($MN)
  • Table 36 Global Protein Purification and Isolation Market Outlook, By Target Identification (2020-2028) ($MN)
  • Table 37 Global Protein Purification and Isolation Market Outlook, By End User (2020-2028) ($MN)
  • Table 38 Global Protein Purification and Isolation Market Outlook, By Academic Medical Institutes (2020-2028) ($MN)
  • Table 39 Global Protein Purification and Isolation Market Outlook, By Hospitals & Diagnostics Centers (2020-2028) ($MN)
  • Table 40 Global Protein Purification and Isolation Market Outlook, By Pharmaceutical & Biotechnology Companies (2020-2028) ($MN)
  • Table 41 Global Protein Purification and Isolation Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)

Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa Regions are also represented in the same manner as above.